Montreal's Methylgene Completes New Financing Round

MethylGene Inc., a Montreal-based biopharmaceuticals firm, announced the completion of a new financing totaling C$26.1 million. The investment was led by Tavistock Life Sciences, a company insider, and included OrbiMed Advisors LLC, Tang Capital Partners LP, RA Capital Management and BVF Partners LP .

ManagersCanadaNorth AmericaBriefs